News
Scroll through our latest news and be the first to know about important developments
Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood
Introduction: Identifying hydatidiform moles (HMs) is crucial due to the risk of gestationaltrophoblastic neoplasia. When a HM is suspected on clinical findings, surgical termination isrecommended.
Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease‐causing variants
Objectives: Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries. A
Remembering Steen
We pay tribute to Prof. Steen Kølvraa, one of the founders of ARCEDI Bitoech, and a pioneer in the fetal cell research in Denmark, who passed away six years ago on 31st March 2016.
ARCEDI featured by Danish Ministry
ARCEDI’s fetal cell-based noninvasive prenatal technology gets featured in a video by the Ministry of Industry, Business and Financial Affairs, Denmark.
Cell-Based NIPT Detects 47,XXY Genotype in a Twin Pregnancy
Background: The existing risk of procedure-related miscarriage following invasive sampling for prenatal diagnosis is higher for twin pregnancies and some women are reluctant to test
Presentation at CoGEN-2021
Line Dahl Jeppesen presents her PhD project at CoGEN-2021 meeting Line Dahl Jeppesen who is doing her PhD at ARCEDI Biotech presented a talk at the 8th CoGEN meeting
